ESC 2010: Further evidence of superiority of Xience V over Cypher
This article was originally published in Clinica
Executive Summary
Abbott's Xience V drug-eluting stent (DES) appears to be safer than Cypher, Johnson & Johnson's older DES, and may be associated with lower rates of stent thrombosis over the long term.